Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis

Abstract

It is increasingly clear that the CD40 and CD40 ligand (CD40L) receptor-ligand pair mediates a crucial activation signal in both cell-mediated and humoral immune responses. Here, we detected mRNA levels of CD40 and CD40L in non-stimulated peripheral blood mononuclear cells in 46 patients with multiple sclerosis (MS) and 46 healthy controls by a competitive RT-PCR procedure allowing quantification without previous culture or antigenic stimulation. The levels of CD40 and CD40L mRNA were markedly increased in MS patients (P <0.0001) compared with healthy controls. There was no difference between clinical MS subgroups or stage of disease. Our findings indicate that, although MS is an organ specific disorder an increased signaling via the CD40 and CD40L pathway may be present at the systemic level. The nature of this upregulation, whether primary or secondary to the organ-specific autoimmune response, is yet to be determined. Since interference with CD40/CD40L is an effective way to interfere with autoimmune model diseases such as experimental autoimmune encephalomyelitis, it may be relevant to investigate further the role of these molecules in the pathogenesis of MS.

Keywords

multiple sclerosis CD40 CD40 ligand Reverse transcription polymerase chain reaction (RT-PCR)

Get full access to this article

View all access options for this article.

References

Farrington M et al. (1994) CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency . Proc Natl Acad Sci USA 91: 1099-1103 .

Roy M et al. (1995) Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses . Eur J Immunol 25: 596-603 .

Schoenberger SP et al. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions . Nature 393: 480-483 .

Tian L , Noelle RJ , Lawrence DA. (1995) Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1 . Eur J Immunol 25: 306-309 .

Tan J et al. (1999) Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis . J Neuroimmunol 97: 77-85 .

Durie FH et al. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 . Science 261: 1328-1330 .

Gerritse K et al. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis . Proc Natl Acad Sci USA 93: 2499-2504 .

Mohan C , Shi Y , Laman JD , Datta SK. (1995) Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis . J Immunol 154: 1470-1480 .

Stuber E , Strober W , Neurath M. (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion . J Exp Med 183: 693-698 .

10.

Griggs ND et al. (1996) The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells . J Exp Med 183: 801-810 .

11.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 227-231 .

12.

Chomczynski P , Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction . Anal Biochem 162: 156-159 .

13.

Celi FS , Zenilman ME , Shuldiner AR. (1993) A rapid and versatile method to synthesize internal standards for competitive PCR . Nucl Acids Res 21: 1047-1047 .

14.

Huang W-X , Huang P , Link H , Hillert J. (1999) Cytokine analysis in multiple sclerosis by competitive RT - PCR: A decreased expression of IL-10 and an increased expression of TNF-α in chronic progression . Multiple Sclerosis 5 342-348 .

15.

Grewal IS et al. (1996) Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis . Science 273: 1864-1867 .

16.

Samoliova EB , Horton JL , Zhang HD , Chen YH. (1997) CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation . J Mol Med 75: 603-608 .

17.

Howard LM et al. (1999) Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis . J Clin Invest 103: 281-290 .

18.

Kooten C , Banchereau J. (1997) Functional role of CD40 and its ligand . Int Arch Allergy Immunol 113: 393-399 .

19.

Kirk AD et al. (1999) Treatment with humanized monoclonal antibody against CD 154 prevents acute renal allograft rejection in nonhuman primates . Nature Medicine 5: 686-693 .

20.

Balashov KE et al. (1997) Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand . Proc Natl Acad Sci USA 94: 599-603 .

21.

Kennedy MK et al. (1996) CD40/CD40 ligand interactions are required for T cell-dependent production of inter-leukin-12 by mouse macrophages . Eur J Immunol 26: 370-378 .

22.

Segal BM , Dwyer BK , Shevach EM. (1998) An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease . J Exp Med 187: 537-546 .

23.

Matusevicius D et al. (1998) Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis . Scand J Immunol 47: 582-590 .